Skip to main content

Table 3 Composition of medical costs for lung cancer patients

From: Differences in medical costs among urban lung cancer patients with different health insurance schemes: a retrospective study

 

UEBMI

URBMI

Overall

P–value

Median drug cost (RMB)

6419

4477

5897

< 0.001

IQR

[3008–12,122]

[1943–8519]

[2679–11,270]

 

Median TCM cost (RMB)

945

556

834

< 0.001

IQR

[47–2497]

[227–1665]

[36–2286]

 

Median medical service cost (RMB)

3172

2603

3015

< 0.001

IQR

[1673–6821]

[1446–5286]

[1608–6407]

 

Median medical consumable cost (RMB)

263

207

247

< 0.001

IQR

[90–765]

[70–560]

[84–709]

 

Effective reimbursement rate

83.33%

65.61%

79.09%

< 0.001

  1. IQR Interquartile range, TCM Traditional Chinese medicine (including Chinese patent medicine and Chinese herbal medicine), UEBMI Urban Employees’ Basic Medical insurance, URBMI Urban Residents’ Basic Medical Insurance